Nanoparticle Technology for Immune Response Against Small and Macromolecules-Method of Preparation and Uses Thereof
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides synthetic nanocarriers capable of eliciting an immune system response in the form of antibody production, wherein the nanocarriers lack any T cell antigens. In some embodiments, the invention provides nanocarriers that comprise an immunofeature surface, which provides high avidity binding of the nanocarriers to antigen presenting cells. The invention provides pharmaceutical compositions comprising inventive nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive nanocarriers and pharmaceutical compositions thereof.
Researchers
-
immunonanotherapeutics that provide igg humoral response without t-cell antigen
United States of America | Granted | 8,277,812 -
adjuvant incorporation in immunonanotherapeutics
United States of America | Granted | 8,343,498 -
adjuvant incorporation in immunonanotherapeutics
Korea (south) | Granted | 10 -
immunonanotherapeutics that provide igg humoral response without t-cell antigen
United States of America | Granted | 8,906,381 -
adjuvant incorporation in immunonanotherapeutics
Israel | Granted | 212,240 -
adjuvant incorporation in immunonanotherapeutics
China | Granted | 0 -
adjuvant incorporation in immunonanotherapeutics
United States of America | Granted | 8,637,028 -
immunonanotherapeutics
European Patent Convention | Granted | 2,344,186 -
adjuvant incorporation in immunonanotherapeutics
Russian Federation | Granted | 2,496,517 -
adjuvant incorporation in immunonanotherapeutics
United States of America | Granted | 9,233,072 -
adjuvant incorporation in immunonanotherapeutics
United States of America | Granted | 9,439,859
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.